Key result
Interatrial shunt devices emerge as potential alternative treatments to unload left atrial pressure in HF.
Why the study?
Compared with left ventricular remodeling, atrial structural and functional changes in heart failure have received less attention, while left atrial pressure has emerged as a novel target for advanced monitoring and therapeutic decompression.
Left atrial pressure monitoring and decompression are emerging as novel targets for optimizing heart failure treatment.
LAP monitoring and decompression emerge as novel HF targets; leaves open randomized validation of interatrial shunts before clinical adoption.
Comprehensive knowledge of the left atrium (LA) and its pathophysiology has emerged as an important clinical and research focus in the heart failure (HF) arena. Although studies on HF focusing on investigating left ventricular remodeling are numerous, those on atrial structural and functional changes have received comparatively less attention. Studies on LA remodeling have recently received increasing attention, and LA pressure (LAP) has become a novel target for advanced monitoring and is a potential therapeutic approach for treating HF. Various devices specifically designed for the direct measurement of LAP have been developed to optimize HF treatment by reducing LAP. This review focuses on LA hemodynamic monitoring and effective LAP decompression.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2024) conducted a review in Heart Failure. Left atrial decompression devices (e.g., Interatrial Shunt Devices) was evaluated. Elevated left atrial pressure drives heart failure symptoms, and device-based therapies such as interatrial shunt devices are emerging as potential alternative treatments to unload left atrial pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: